Hans-Peter Gerber
Equibles does not estimate personal net worth.
Get an email with a short summary when Sutro Biopharma, Inc. publishes a filing, an earnings call transcript or a press release.
Get STRO alertsAbout Hans-Peter Gerber
The proxy statement of Sutro Biopharma, Inc. reports total compensation of $942,902 for Hans-Peter Gerber in fiscal 2025, including a base salary of $527,532. Disclosed compensation is on record for 2 fiscal years. Sutro Biopharma, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Sutro Biopharma, Inc. includes Jane Chung (CEO, COO and Board Member), Gregory Chow (CFO), Gregory K. Chow (CFO) and 5 others.
Affiliation history
-
Sutro Biopharma, Inc. (STRO)
Proxy statement
CurrentStart not stated–present
Last confirmed April 22, 2026
Company network
Leadership on record at Sutro Biopharma, Inc.
- Jane Chung CEO, COO, Board Member
- Gregory Chow CFO
- Gregory K. Chow CFO
- David Pauling General Counsel
- Heidi Hunter Board Member
- James Panek Board Member
- Jon Marc Wigginton, M.D. Board Member
- Sukhi Jagpal Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Sutro Biopharma, Inc. (STRO) | Chief Scientific Officer | $527,532 | $942,902 |
| 2024 | Sutro Biopharma, Inc. (STRO) | Chief Scientific Officer | $512,500 | $1,153,932 |
Recent activity
No call appearances or filed executive changes recorded yet.